Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer

Neoplasma

Volumn 44, Issue 4, 1997, Pages 219-239

  Krepela E ^a   Prochazka J ^a   Karova B ^a   Cermak J ^a   Roubkova H ^a  

^a UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

Cathepsin B; Cathepsin C; Cysteine; Cysteine protease inhibitors; Glutathione; Squamous cell lung carcinoma; glutamyltransferase

Indexed keywords

CATHEPSIN B; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; PROTEINASE INHIBITOR;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; ISOELECTRIC FOCUSING; LUNG BIOPSY; LUNG SQUAMOUS CELL CARCINOMA; MALE; PROTEIN DETERMINATION;

EID: 0030796651     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. ASHANI, Y., CATRAVAS, G. N.: Highly reactive impurities in Triton X-100 and Brij 35, partial characterization and removal. Anal. Biochem., 109, 1980, 55-62.
2. AUTHIER, F., POSNER, B.I., BERGPRON, J.J.M.: Endosomal protcolysis of internalized proteins. FEBS Lett., 389, 1996, 55-60.
3. BAICI, A., GYGER-MARAZZI, M.: The slow, tight-binding inhibition of cathepsin B by leupeptin. A hysteretic effect. Eur. J. Biochem., 129, 1982, 33-41.
4. BARRETT, A.J., DAVIES, E.M., GRUB, A.: The place of human γ-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem. Biophys. Res. Commun., 120, 1984, 631-636.
5. BARRETT, A.J., KEMBHAVI, A.A., BROWN, M.A., KIRSCHKE, H., KNIGHT, C.G., TAMAI, M., HANADA, K.: L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J., 201, 1982, 189-198.
6. BARRETT, A.J., KIRSCHKE, H.: Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol., 80, 1981, 535-561.
7. BARRETT, A.J., RAWLINGS, N.D., DAVIES, E.M., MACHLEIDT, W., SALVESSEN, G., TURK, V.: Cysteine proteinase inhibitors of the cystatin superfamily. In: Proteinase Inhibitors. Eds: Barrett, A.J., Salvessen, G. Amsterdam, Elsevier 1986, 515-569.
8. BERG, T., GJøEN, T., BAKKE, O.: Physiological functions of endosomal proteolysis. Biochem. J., 307, 1995, 313-326.
9. BLACKMON, D.L., WATSON, A.J.M., MONTROSE, M.H.: Assay of apical membrane enzymes based on fluorogenic substrates. Anal. Biochem., 200, 1992, 352-358.
10. BURNETT, D., ABRAHAMSON., M., DEVALIA, J.L., SAPSFORD, R.J., DAVIES, R.J., BUTTLE, D.J.: Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase. Arch. Biochem. Biophys., 317, 1995, 305-310.
11. CHAGAS, J.R., FERRER-DI MARTINO, M., GAUTHIER, F., LALMANACH, G.: Inhibition of cathepsin B by its propeptide: use of overlapping peptides to identify a critical segment. FEBS Lett., 392, 1996, 233-236.
12. CHAN, W.W.C.: Combination plots as graphical tools in the study of enzyme inhibition. Biochem. J., 311, 1995, 981-985.
13. CHAPMAN, JR. H.A, REILY, JR. J.J., YEE, R., GRUBB, A.: Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. Am. Rev. Respir. Dis., 141, 1990, 698-705.
14. CHEN, Y., PLOUFFE, C., MENARD, R., STORER, A.C.: Delineating functionally important regions and residues in the cathepsin B propeptide for inhibitory activity. FEBS Lett., 393, 1996, 24-26.
15. COETZER, T.H.H., DENNEHY, K.M., PIKE, R.N., DENNISON, C.: Baboon (Papio ursinus) cathepsin L: purification, characterization and comparison with human and sheep cathepsin L. Comp. Biochem. Physiol., 112B, 1995, 429-439.
16. COLLINS, D.S., UNANUE, E.R., HARDING, C.V.: Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J. Immunol., 147, 1991, 4054-4059.
17. COOK, J.A., PASS, H.I., IYPE, S.N., FRIEDMAN, N., DEGRAFF, W., RUSSO, A., MITCHELL, J.B.: Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue. Cancer Res., 51, 1991, 4287-4294.
18. CYGLER, M., SIVARAMAN, J., GROCHULSKI, P., COULOMBE, R., STORER, A.C., MORT, J.S.: Structure of rat procathepsin B: Model for inhibition of cysteine protease activity by the proregion. Structure, 4, 1996, 405-416.
19. EBERT, W., KNOCH, H., WERLE, B., TREFZ, G., MULEY, T., SPIESS, E.: Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res., 14, 1994, 895-900.
20. FOX, T., DE MIGUEL, E., MORT, J.S., STORER, A.C.: Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry, 31, 1992, 12571-12576.
21. GAINEY, D., SHORT, S., MCCOY, K.: Intracellular location of cysteine transport activity correlates with productive antigen processing. J. Cell Physiol., 168, 1996, 248-254.
22. GATTI, R., CAVRINI, V., ROVERI, P., PINZAUTI, S.: High-performance liquid chromatographic determination of aliphatic thiols with aroylacrylic acids as fluorogenic precolumn dcrivatization reagents. J. Chromatogr., 507, 1990, 451-458.
23. GOLDSTEIN, S., CZAPSKI, G.: Mechanism of the nitrosation of thiols and amines by oxygenated NO solutions: the nature of the nitrosating intermediates. J. Am. Chem. Soc., 118, 1996, 3419-3425.
24. HEIDTMANN, H.H., SALGE, U., HAVEMANN, K., KIRSCHKE, H., WIEDERANDERS, B.: Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines. Oncol. Res., 5, 1994, 441-451.
25. HIWASA, T., FUJITA-YOSHIGAKI, J., SHIROUZU, M., KOIDE, H., SAWADA, T., SAKIYAMA, S., YOKOYAMA, S.: c-Ha-Ras mutants with point mutations in Gln-Val-Val region have reduced inhibitory activity toward cathepsin B. Cancer Lett., 69, 1993, 161-165.
26. HIWASA, T., YOKOYAMA, S., HA, J.M., NOGUCHI, S., SAKIYAMA, S.: c-Ha-Ras gene products are potent inhibitors of cathepsin B and L. FEBS Lett., 211, 1987, 23-26.
27. INOUE, T., ISHIDA, T., SUGIO, K., SUGIMACHI, K.: Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res., 54, 1994, 6133-6136.
28. JENSEN, P.E.: Reduction of disulfide bond during antigen processing: evidence from a thiol-dependent insulin determinant. J. Exp. Med., 174, 1991, 1121-1130.
29. JIA, Z., HASNAIN, S., HIRAMA, T., LEE, X., MORT, J.S., TO, R., HUBER, C.P.: Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design. J. Biol. Chem., 270, 1995, 5527-5533.
30. KALNITSKY, G., CHATTERJEE, R., SINGH, H., LONES, M., PASZKOWSKI, A.: Bifunctional activities and possible modes of regulation of some lysosomal cysteinyl proteases. In: Proteinase Inhibitors: Medical and Biological Aspects. Eds: Katunuma, N., Umezawa, H., Holzer, H. Tokyo, Japan Sci. Soc. Press, Berlin, Springer-Verlag 1983, 263-273.
31. KHARITONOV, V.G., SUNDQUIST, A., SHARMA, V.S.: Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J. Biol. Chem., 270, 1995, 28158-28164.
32. KIRSCHKE, H., BARRETT, A.J., RAWLINGS, N.D.: Proteinases 1: Lysosomal Cysteine Proteinases. Protein Profile, Vol. 2, 1995, 1587-1643.
33. KNIGHT, C.G.: Human cathepsin B. Application of the substrate N-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide to a study of the inhibition by leupeptin. Biochem. J., 189, 1980, 447-453.
34. KNOCH, H., WERLE, B., EBERT, W., SPIESS, E.: Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer. Int. J. Oncol., 5, 1994, 77-85.
35. KOCH, C.J., EVANS, S.M.: Cysteine concentrations in rodent tumors: unexpectedly high values may cause therapy resistance. Int J. Cancer., 67, 1996, 661-667.
36. KŔEPELA, E., KASAFİREK, E., NOVÁK, J., VYKLICKÝ, J.: Increased cathepsin B activity in human lung cancer. Neoplasma, 37, 1990, 61-70.
37. KŔEPELA, E., PROCHÁZKA, J., MYNAŔÍKOVÁ, H., KÁROVÁ, B., ČERMÁK, J., ROUBKOVA, H.: Lysosomal dipeptidyl-peptidases I and II in human squamous-cell lung carcinoma and lung parenchyma. Neoplasma, 43, 1996, 171-178.
38. KŔEPELA, E., PROCHÁZKA, J., MYNAŘÍKOVÁ, H., KÁROVÁ, B., POLÁK, J., ČERMÁK, J., ROUBKOVÁ, H.: Multiple forms of cathepsin B in human lung cancer. Int. J. Cancer, 61, 1995, 44-53.
39. KYLLÓNEN, A.P., JÄRVINEN, M., HOPSU-HAVU, V.K., DORN, A., RÄSÄNEN, O., LARMI, T., RINNE, A.: The behaviour of small molecular cysteine proteinase inhibitors in lung cancers and in surrounding tissue. Acta Histochem., 74, 1984, 109-113.
40. LLOYD, J.B.: Lysosomal handling of cystine residues: stoichiometry of cysteinc involvement. Biochem. J., 286, 1992,979-980.
41. MCDONALD, J. K., BARRETT, A.J.: Mammalian Proteases: A Glossary and Bibliography, Vol. 2. Exopeptidases. London, Academic Press 1986, 279-280.
42. MOUNTAIN, C.F.: The new international staging system for lung cancer. Surg. Clin. N. Am., 67, 1987, 925-935.
43. NATHAN, C.: Nitric oxide as a secretory product of mammalian cells. FASEB J., 6, 1992, 3051-3064.
44. NICKLIN, M.J.H., BARRETT, A.J.: Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin. Biochem. J., 223, 1984, 245-253.
45. NIKAWA, T., TOWATARI, T., KATUNUMA, N.: Purification and characterization of cathepsin J from rat liver. Eur. J. Biochem., 204, 1992, 381-393.
46. OKUMICHI, T., NISHIKI, M., TAKASUGI, S., YAMANE, M., EZAKI, H.: Purification of thiol protease inhibitor from human lung cancer tissue. Hiroshima J. Med. Sci., 33, 1984, 801-808.
47. OZEKI, Y., TAKISHIMA, K., TAKAGI,K., AIDA,S., TAMAI,S., MAMIYA, G., OGATA, T.: Immunohistochemical analysis of cathepsin B expression in human lung adenocarcinoma: the role in cancer progression. Jpn. J. Cancer. Res., 84, 1993, 972-975.
48. PETIT, J.F., NICAISE, M., LEPOIVRE, M., GUISSANI, A., LEMAIRE, G.: Protection by glutathione against the antiproliferative effects of nitric oxide. Biochem. Pharmacol., 52, 1996, 205-212.
49. PISONI, R.L.,ACKER, T.L., LISOWSKI, K.M., LEMONS, R.M.,THOENE, J.G.: A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: Possible role in supporting lysosomal proteolysis. J. Cell Biol., 110, 1990, 327-335.
50. PISONI, R.L., THOENE, J.G.: The transport systems of mammalian lysosomes. Biochim. Biophys. Acta., 1071, 1991, 351-373.
51. RABENSTEIN, D.L., WEAVER, K.H.: Kinetics and equilibria of the thiol/disulfide exchange reactions of somatostatin with glutathione. J. Org. Chem., 61, 1996, 7391-7397.
52. RANKIN, B.B., MCINTYRE, T.M., CURTHOYS, N.P.: Brush border membrane hydrolysis of S-benzyl-cysteine-p-nitroanilide, an activity of aminopeptidase M. Biochem. Biophys. Res. Commun., 96, 1980, 991-996.
53. REDDY, V.Y., ZHANG, Q.Y., WEISS,S.J.: Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA, 92, 1995, 3849-3853.
54. ROVERI, P., CAVRINI, V., ANDRISANO, V., GATTI, R.: Thin-layer chromatography of aliphatic thiols after fluorescent labelling with methyl 4-(6-methoxynaphthalen-2-yl)-4-oxo-2-butenoate. J. Liquid Chromatogr., 16, 1993, 1859-1866.
55. SINGH, R., LAMOUREUX, G., LEES, W.J., WHITESIDES, G.M.: Reagents for rapid reduction of disulfide bonds. Methods Enzymol., 251, 1995, 167-173.
56. SMITH, G.D., DING, J.L., PETERS, T.J.: A sensitive fluorimetric assay forγ-glutamyl transferase. Anal. Biochem., 100, 1979, 136-139.
57. SMITH, P.K., KROHN, R.I., HERMANSON, G.T., MALLIA, A.K., GARTNER, F.H., PROVENZANO, M.D., FUJIMOTO, E.K., GOEKE, N.M., OLSON, B.J., KLENK, D.C.: Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 1985, 76-85.
58. SPIESS, E., BRÚNNING, A., GACK, S., ULBRICHT, B., SPRING, H., TREFZ, G., EBERT, W.: Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity and inhibitor status at the cellular level. J. Histochem. Cytochem., 42, 1994, 917-929.
59. r inhibitors of trypsin-catalysed hydrolysis. Characterization by kinetic analysis and by energy minimization and molecular dynamics simulation of the E-64-β-trypsin complex. Biochem. J., 316, 1996, 777-786.
60. SUKOH, N., ABE, S., NAKAJIMA, L, OGURA, S., ISOBE, H., INOUE, K., KAWAKAMI, Y.: Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis. Virchows Arch., 424, 1994, 33-38.
61. SUKOH, N., ABE, S., OGURA, S., ISOBE, H., TAKENAWA, H., INOUE, K., KAWAKAMI, Y: Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer, 74, 1994, 46-51.
62. SZEGO, C.M., SEELER, B.J., SMITH, R.E.: Lysosoinal cathepsin B1: partial characterization in rat preputial gland and recompartmentation in response to estradiol-17β. Eur. J. Biochem., 69, 1976, 463-474.
63. ŠEDO, A., KŘEPELA, E., KASAFÍREK., E.: Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumours and lung parenchyma. J. Cancer Res. Clin. Oncol., 117, 1991, 249-253.
64. TEW, K.D., MONKS, A., BARONE, L., ROSSER, D., AKERMAN, G., MONTALI, J.A., WHEATLEY, J.B., SCHMIDT JR., D.E.: Glutathione-associated enzymes in the human cell lines of the National Cancer Institute drug screening program. Mol. Pharmacol., 50, 1996, 149-159.
65. TURK, D., PODOBNIK, M., KUHEIJ, R., DOLINAR, M., TURK, V.: Crystal structures of human procathepsin B at 3.2 and 3.3 Å resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide. FEBS Lett., 384, 1996, 211-214.
66. ULBRICHT, B., SPIESS, E., SCHWARTZ-ALBIEZ, R., EBERT, W.: Quantification of intracellular cathepsin activities in human lung tumor cell lines by flow cytometry. Biol. Chem. Hoppe-Seyler, 376, 1995, 407-414.
67. ULBRICHT, B., HAGMANN, W., EBERT, W., SPIESS, E.: Differential secretion of cathepsin B and L from normal and tumor human lung cells stimulated by 12(S)-hydroxy-eicosatetraenoic acid. Exp. Cell Res., 226, 1996, 255-263.
68. WARFEL, A.H., CARDOZO, C., YOO, O.H., ZUCKER-FRANKLIN, D.: Cystatin C and cathepsin B production by alveolar macrophages from smokers and nonsmokers. J. Leuk. Biol., 49, 1991, 41-47.
69. WERLE, B., EBERT, W., KLEIN, W., SPIESS, E.: Cathepsin B in tumors, normal tissue and isolated cells from the human lung. Anticancer Res., 14, 1994, 1169-1176.
70. WERLE, B., EBERT, W., KLEIN, W., SPIESS, E.: Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue. Biol. Chem. Hoppe-Seyler, 376, 1995, 157-164.
71. WERLE, B., EBERT, W., KLEIN, W., SPIESS, E.: Charge polymorphism in human lung cell pro-cathepsin B. Anticancer Res., 16, 1996, 49-54.
72. WHITE, A.C., MALONEY, E.K., BOUSTANI, M.R., HASSOUN, P.M., FANBURG, B.L.: Nitric oxide increases cellular glutathione levels in rat lung fibroblasts. Am. J. Respir. Cell Mol. Biol., 13, 1995, 442-448.
73. WILCOX,D., MASON, R.W.: Inhibition of cysteine proteinases in lysosomes and whole cells. Biochem. J., 285, 1992, 495-502.
74. WILLENBROCK, F., BROCKLEHURST, K.: A general framework of cysteine-proteinasc mechanism deduced from studies on enzymes with structurally different analogous catalytic-site residuesAsp-158 and -161 (papain and actinidin), Gly-196 (cathcpsin B) and Asn-165 (cathepsin H). Kinetic studies up to pH 8 of the hydrolysis ofN-α-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide catalysed by cathepsin B and ofL-arginine 2-naphthylamide catalysed by cathepsin H. Biochem. J., 227, 1985, 521-528.
75. World Health Organization histological typing of lung tumours. Am. J. Clin. Pathol., 77, 1982, 123-136.
76. XIE, K., DONG, Z., FIDLER, I.J.: Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leuk, Biol., 59, 1996, 797-803.